Cytokine Signalling Forum

PsA Podcast: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Informações:

Sinopsis

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.